Moneycontrol
Get App
SENSEX NIFTY
you are here:

Marksans Pharma Ltd.

BSE: 524404 | NSE: MARKSANS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE750C01026 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Jan 20, 13:14
19.90 -0.35 (-1.73%)
Volume
AVERAGE VOLUME
5-Day
199,103
10-Day
178,511
30-Day
189,555
174,395
  • Prev. Close

    20.25

  • Open Price

    20.60

19.90

Today’s L/H

20.75
11.45

52 Wk L/H

28.60
16.20

L/U Price Band

24.30
  • Bid Price (Qty.)

    19.85 (2788)

  • Offer Price (Qty.)

    19.95 (13531)

  •  VWAP

    20.27
     Beta
    1.32
  • Market Depth (20 Jan 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    2788 19.85 19.95 13531
    7271 19.80 20.00 2502
    2480 19.75 20.05 4316
    1386 19.70 20.10 784
    5927 19.65 20.15 891
    53638 Total Total 123538
     Market Depth
    BUY 53.64 K
    SELL 1.24 L
    30%
    70%

NSE Live

Jan 20, 13:14
19.85 -0.35 (-1.73%)
Volume
AVERAGE VOLUME
5-Day
1,844,633
10-Day
1,661,005
30-Day
1,894,486
1,410,907
  • Prev. Close

    20.20

  • Open Price

    20.50

19.85

Today’s L/H

20.75
11.40

52 Wk L/H

28.65
16.20

L/U Price Band

24.20
  • Bid Price (Qty.)

    19.85 (2280)

  • Offer Price (Qty.)

    19.90 (5882)

  •  VWAP

    20.30
     Beta
    1.38
  • DELIVERY AVERAGES
    3-Day
    41.26%
    5-Day
    41.54%
    8-Day
    40.77%
    Deliverables
  • SMA VOLUME
    30
    16.95
    50
    16.04
    150
    16.22
    200
    18.11
    SMA
    16.95

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Very Bullish
Moving Averages Bullish
Technical Indicators Bullish
Moving Averages Crossovers Bullish
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 20.50 20.80 21.20 20.10 19.80 19.40 19.10
Fibonacci 20.37 20.53 20.80 20.10 19.83 19.67 19.40
Camarilla 20.26 20.33 20.39 20.10 20.14 20.07 20.01

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 19.67
10 18.85
20 17.96
50 16.14
100 15.21
200 18.09
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Valuation

    • Market Cap (Rs Cr.)
      816.58
    • P/E
      23.41
    • Book Value (Rs)
      11.50
    • Dividend (%)
      5.00
    • Market Lot
      1
    • Industry P/E
      31.15
    • EPS (TTM)
      0.85
    • P/C
      18.6
    • Price/Book
      1.73
    • Dividend Yield.(%)
      0.25
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      41.26
      5-Day
      41.54
      8-Day
      40.77
      43.40

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      816.58
    • P/E
      9.75
    • Book Value (Rs)
      13.50
    • Dividend (%)
      5.00
    • Market Lot
      1
    • Industry P/E
      31.15
    • EPS (TTM)
      2.04
    • P/C
      7.67
    • Price/Book
      1.48
    • Dividend Yield.(%)
      0.25
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      41.26
      5-Day
      41.54
      8-Day
      40.77
      43.40

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

  • 95% BUY
  • 5% SELL
  • 0% HOLD
95%
of moneycontrol users recommend buying Marksans Pharma

What's your call on Marksans Pharma today?

Read 7 investor views

BUY SELL HOLD

Action in Marksans Pharma Ltd.

  • Technicals

    Marksans Pharma closes above 200-Day Moving Average of 18.20 today.

    Jan 13

  • Technicals

    Marksans Pharma closes above 200-Day Moving Average of 18.45 today.

    Jan 03

  • Technicals

    Marksans Pharma closes above 150-Day Moving Average of 16.66 today.

    Dec 31

  • Technicals

    Marksans Pharma closes above 150-Day Moving Average of 16.93 today.

    Dec 17

  • Technicals

    Marksans Pharma closes above 30-Day,50-Day Moving Average today.

    Dec 16

  • Technicals

    Marksans Pharma closes above 50-Day Moving Average of 14.24 today.

    Dec 13

  • Technicals

    Marksans Pharma closes below 30-Day Moving Average of 14.71 today.

    Nov 28

  • Technicals

    Marksans Pharma closes above 50-Day Moving Average of 14.37 today.

    Nov 18

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 14.04 today.

    Oct 28

  • Technicals

    Marksans Pharma closes above 50-Day Moving Average of 14.57 today.

    Oct 21

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 14.12 today.

    Oct 17

  • AGM/EGM

    Marksans Pharma AGM on Sep 26, 2019, Announcement date: Aug 28, 2019

    Sep 25, 11:00

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 15.23 today.

    Sep 10

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 15.23 today.

    Sep 09

  • Only Buyers

    Only Buyers in Marksans Pharma on BSE

    Jul 31, 14:45

  • 52 Week Low

    Marksans Pharma has hit 52wk low of Rs 15.05 on NSE

    Jul 30, 09:16

  • 52 Week Low

    Marksans Pharma has hit 52wk low of Rs 15.05 on BSE

    Jul 18, 09:18

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 23.52 today.

    May 27

  • 52 Week Low

    Marksans Pharma has hit 52wk low of Rs 21.70 on NSE

    May 14, 09:16

  • Technicals

    Marksans Pharma closes below 50-Day Moving Average of 24.87 today.

    Apr 22

News & Videos

Data not available

News across the web

Data not available

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Jan 20, 09:15
20.60 0.35 (1.73%)
High 20.60
Low 20.50
Prev. Close 20.25

NSE

Jan 20, 09:15
20.50 0.30 (1.49%)
High 20.50
Low 20.25
Prev. Close 20.20

Financials

Income Statement

  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 100.72 92.42 91.18 125.19 114.65
Other Income 7.87 2.15 9.50 0.12 2.80
PBDIT 12.79 10.27 3.37 17.35 17.81
Net Profit 11.86 5.66 5.62 11.78 12.34
  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 256.40 245.03 247.41 248.37 269.04
Other Income 7.88 2.18 9.73 0.16 -0.80
PBDIT 33.57 32.42 15.65 36.19 37.12
Net Profit 25.97 22.48 9.85 25.13 20.57

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 50.93 50.93
Networth 480.57 438.97
Total Debt 77.33 66.31
Net Block 102.61 87.89
Investments 236.07 236.07
Total Assets 557.89 505.26

Historical Prices

On
Current Price %Gain / Loss
Open Price 28.05 20.60
-26.56
High Price 28.60 20.75
-27.45
Low Price 27.90 19.90
-28.67
Close Price 27.95 20.25
-27.55
Volume 193,699 174,395
-9.97
On
Current Price %Gain / Loss
Open Price 27.95 20.50
-26.65
High Price 28.65 20.75
-27.57
Low Price 27.85 19.85
-28.73
Close Price 27.95 20.20
-27.73
Volume 1,135,445 1,411,407
24.3
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 12251.80 -100.60 -0.81
SENSEX 41618.48 -326.89 -0.78
NIFTY BANK 31220.30 -370.35 -1.17
NIFTY IT 16191.50 -165.10 -1.01
S&P BSE Smallcap 14678.59 -30.11 -0.20
Index Price Change %Chg
Straits Times (Jan 20) 3,276.67 -4.36 -0.13
Shanghai Composite (Jan 20) 3,095.79 20.29 0.66
KOSPI (Jan 20) 2,262.64 12.07 0.54
Nikkei 225 (Jan 20) 24,083.51 42.25 0.18
SGX Nifty (Jan 20) 12,275.00 -107.50 -0.87

CORPORATE ACTION

Date Agenda
Nov 12, 2019 Quarterly Results
Aug 09, 2019 Quarterly Results
May 29, 2019 Audited Results & Final Dividend
Feb 08, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Final 5.00 Sep 19, 2019
Final 5.00 Sep 19, 2018
Final 5.00 Sep 19, 2017
Final 12.00 Sep 22, 2016
Final 12.00 Sep 23, 2015
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Marksans Pharma
Old FV New FV Ex-Split
10 1 Mar 11, 2008
Ratio Premium Ex-Bonus
No Rights Information is available for Marksans Pharma
Date Agenda
Sep 26, 2019 -
Sep 27, 2018 -
Sep 26, 2017 -
Sep 29, 2016 Rs.0.1200 per share(12%)Dividend
Sep 29, 2015 Rs.0.1200 per share(12%)Dividend

Dividend Summary

For the year ending March 2019 Marksans Pharma has declared an equity dividend of 5.00% amounting to Rs 0.05 per share. At the current share price of Rs 20.10 this results in a dividend yield of 0.25%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2019 March 2019 December 2018 September 2018
Promoters 48.25 48.25 48.25 48.25
Pledged 0 0 0 0
FII/FPI 2.66 2.72 2.62 2.98
Total DII 7.57 7.82 8.11 9.03
Fin.Insts 0.29 0.4 0.32 0.36
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 7.28 7.42 7.79 8.67
Others 41.52 41.21 41.03 39.73
Total 100 100 100.01 99.99

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr

COMPANY OVERVIEW

Marksans Pharma Limited together with its subsidiaries operates as an integrated international pharmaceutical company. The Companys business is distribution of pharmaceutical products. It is actively engaged in research and development (R&D) and offering contract research and manufacturing services (CRAMS) to global pharmaceutical companies. The R&D capability of the Company includes dossier development service, formulation development and specified drug delivery system. The Companys domestic formulation business is the specialty division, which mainly focuses on oncology and critical care therapy. The brands of this division are MARKPARIN and EPIGROF. EPIGROF is also being supplied to hospitals and other burns and trauma care institutes. Cerebella division is the specialty division marketing drugs meant for lifestyle diseases, neuro and psychiatric therapy. The brands of this division are BAZZY, CITOFAST, GABELLA, GABELLA M, XENOTRIL, which are the main contributors of sales.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Mark Saldanha

      Chairman & Managing Director

    • Sandra Saldanha

      Whole Time Director

    • Varddhman Vikramaditya Jain

      Whole Time Director

    • Ajay S Joshi

      Independent Director

    • Abhinna Sundar Mohanty

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Marksans Pharma Ltd.

Marksans Pharma is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 524404 and the NSE with an NSE Code of MARKSANS.

Related Searches